Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $28.71 $35.40 Friday, 10th May 2024 AGIO stock ended at $33.00. This is 0.243% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 1.97% from a day low at $32.45 to a day high of $33.09.
90 days $24.69 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Jul 07, 2016 $42.63 $42.63 $42.63 $42.63 442 200
Jul 06, 2016 $43.03 $43.03 $43.03 $43.03 551 800
Jul 05, 2016 $41.47 $41.47 $41.47 $41.47 305 000
Jul 01, 2016 $42.77 $42.77 $42.77 $42.77 735 200
Jun 30, 2016 $41.90 $41.90 $41.90 $41.90 669 200
Jun 29, 2016 $44.60 $44.60 $44.60 $44.60 686 600
Jun 28, 2016 $43.89 $43.89 $43.89 $43.89 787 000
Jun 27, 2016 $40.27 $40.27 $40.27 $40.27 808 800
Jun 24, 2016 $44.27 $44.27 $44.27 $44.27 957 500
Jun 23, 2016 $48.50 $48.50 $48.50 $48.50 950 700
Jun 22, 2016 $47.07 $47.07 $47.07 $47.07 644 100
Jun 21, 2016 $47.33 $47.33 $47.33 $47.33 708 200
Jun 20, 2016 $49.30 $49.30 $49.30 $49.30 508 300
Jun 17, 2016 $47.48 $47.48 $47.48 $47.48 1 045 400
Jun 16, 2016 $48.82 $48.82 $48.82 $48.82 862 164
Jun 15, 2016 $49.66 $49.66 $49.66 $49.66 509 523
Jun 14, 2016 $48.75 $48.75 $48.75 $48.75 1 708 446
Jun 13, 2016 $51.97 $51.97 $51.97 $51.97 3 020 712
Jun 10, 2016 $50.34 $50.34 $50.34 $50.34 1 828 998
Jun 09, 2016 $56.22 $56.22 $56.22 $56.22 3 395 854
Jun 08, 2016 $66.09 $66.09 $66.09 $66.09 1 349 847
Jun 07, 2016 $61.62 $61.62 $61.62 $61.62 874 819
Jun 06, 2016 $59.68 $59.68 $59.68 $59.68 505 895
Jun 03, 2016 $56.80 $56.80 $56.80 $56.80 776 681
Jun 02, 2016 $60.99 $60.99 $60.99 $60.99 874 330
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT